Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori

Gut

Volumn 40, Issue 4, 1997, Pages 463-469

  Konturek, P Ch ^b   Ernst, H ^b   Konturek, S J ^a   Bobrzynski A J ^b   Faller, G ^b   Klingler, C ^b   Hahn, E G ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b NONE

Author keywords

Duodenal ulcer; EGF; EGF receptors; Gastrin; Helicobacter pylori; TGF

Indexed keywords

EPIDERMAL GROWTH FACTOR; PENTAGASTRIN; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPY; GASTRIN BLOOD LEVEL; GASTRODUODENAL ULCER; HELICOBACTER PYLORI; HUMAN; IMMUNOCYTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030926029     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.4.463     Document Type: Article

References (30)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i: 1273-5.
2. Konturek PCh, Konturek SJ. Role of Helicobacter pylori infection in gastroduodenal secretion and in pathogenesis of peptic ulcer and gastritis. J Pharmacol Physiol 1994; 45: 333-50.
3. Hirschi AM. Helicobacter pylori. Klin Wochensch 1994; 106: 536-42.
4. Levi S, Haddad G, Ghosh P, Beardshall K, Playford R, Calam J. Campylobacter pylori and duodenal ulcer; the gastrin link. Lancet 1989; i: 1167-8.
5. Konturek JW, Gillessen A, Konturek SJ, Domschke W. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. Gut 1995; 37: 482-7.
6. Cohen S. Isolation of a mouse submaxillary protein acceleration incisor eruption and eye opening in newborn animal. J Biol Chem 1962; 237: 1555-62.
7. Elder JB, Williams G, Lacey E, Gregory H. Cellular localization of human urogastrone/epidermal growth factor. Nature 1978; 271: 466-7.
8. Gregory H. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 1975; 257: 325-7.
9. Konturek JW, Bielanski W, Konturek SJ, Bogdal J, Oleksy J. Distribution and release of epidermal growth factor in man. Gut 1989; 30: 1194-200.
10. Konturek JW, Brzozowski T, Konturek SJ. Epidermal growth factor in protection, repair, and healing of gastroduodenal mucosa. J Clin Gastroenterol 1991; 13 (suppl): S88-97.
11. Polk WH, Dempsey PJ, Russel WE, Brown PI, Beauchamp RD, Bernard JA, et al. Increased production of transforming growth factor alpha following acute gastric injury. Gastroenterology 1992; 102: 1467-74.
12. Barnard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ. Epidermal growth factor - related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 1995; 108: 564-80.
13. Konturek SJ, Brzozowski T, Majka J, Dembinski A, Slomiany A, Slomiany BL. Transforming growth factor alpha and epidermal growth factor in protection and healing of gastric mucosal injury. Scand J Gastroenterol 1992; 27: 649-55.
14. Lee H, Hansson HA, Norstrom E, Helander HF. Immunoreactivities for epidermal growth factor (EGF) and for EGF receptors in rats with gastric ulcers. Cell Tissue Res 1991; 265: 211-8.
15. Konturek PCh, Brzozowski T, Konturek SJ, Ernst H, Drozdowicz D, Pajdo R, et al. Expression of epidermal growth factor and transforming growth factor alpha during ulcer healing. Scand J Gastroenterol 1997; 32: 6-15.
16. Wright NA, Pike C, Eila G. Induction of a novel epidermal growth factor-secreting cell linkage by mucosal ulceration in human gastrointestinal stem cells, Nature 1990; 343: 82-5.
17. Hansen G, Muller C, Sinha P, Bohnenkamp W, Kottgen E. Gastric ulcer is accompanied by a decrease of epidermal growth factor in gastric juice and saliva. J Clin Chem Clin Biochem 1989; 27: 539-45.
18. Ohmura E, Emoto N, Tsanshima T, Watanabe S, Takeuchi T, Kawamura M, et al. Salivary immunoreactive human epidermal growth factor (IR-hEGF) in patients with peptic ulcer disease. Hepatogastroenterology 1987; 34: 160-3.
19. Calabro A, Orsini B, Brocchi A, Falchini M, Fedi P, Surrenti C. Gastric juice immunoreactivity epidermal growth factor levels in patients with peptic ulcer disease. Am J Gastroenterol 1990; 85: 404-7.
20. Tunio AM, Hobsley M, Epidermal growth factor in saliva and gastric juice the response to histamine. Gut 1995; 37: 335-9.
21. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311-4.
22. Karttunen T, Niemela S, Lehtola J. Helicobacter pylori in dyspeptic patients. Quantitative association with severity of gastritis, intragastric pH and serum gastrin concentration. Scand J Gastroenterol 1992; 26: 124-34.
23. Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991; 6: 209-22.
24. Thomas DM, Nasim MM, Gullick WJ, Alison Mr. Immunoreactivity of transforming growth factor alpha in the normal and adult gastrointestinal tract. Gut 1992; 33: 628-31.
25. Jankowski J, McMenemin R, Yu C, Hopwood D, Wormesley KG. Proliferating cell nuclear antigen in oesophageal diseases: correlation with transforming growth factor alpha expression. Gut 1992; 33: 587-91.
26. Brzozowski T, Konturek P Ch, Ernst H, Stachura J, Konturek SJ, Hahn EG. Gastric adaptation to injury by repeated doses of aspirin strengthens mucosal defence against subsequent exposure to various strong irritants in rats. Gut 1995; 37: 749-57.
27. Lynch DA, Mapstone NP, Clarke AM, Sobala GM, Jackson P, Morrison L, et al. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut 1995; 36: 351-3.
28. Caghill RJ, Xia H, Kilgallen C, Beattle S, Hamilton S, O'Marion C. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci 1995; 40: 1627-31.
29. Thomsen LL, Gavin JB, Tasman-Jones C. Relation of Helicobacter pylori to human gastric mucosa in chronic gastritis of the antrum. Gut 1990; 31: 1230-6.
30. Caghill RJ, Sant S, Beattle S, Hamilton H, O'Marion C. Helicobacter pylori and increased epithelial cell proliferation: a risk factor for cancer. Eur J Gastroenterol Hepatol 1995; 6: 1123-7.